Skip to main content

First Tracks Biotherapeutics, Inc.

TRAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002091349

In the last 90 days, First Tracks Biotherapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 150 institutions reported holding it in 13F filings for Q2 2026, worth $691.6M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by First Tracks Biotherapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $1.76M in total
Insiders trading
1
Net value
−$1.76M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for First Tracks Biotherapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for First Tracks Biotherapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Orwin John ADirector17,995Sep 17, 20264
Ware J. AnthonyDirector15,660Sep 4, 20264
Stone BenjaminChief Business Officer–Aug 18, 20263
Lizzul Paul F.Chief Medical Officer–Aug 18, 20264
Faga DanielPresident, CEO–Aug 18, 20264
Fenton Dennis MDirector10,995Jun 17, 20263
Schmid John P.Director37,652Jun 17, 20263
Marquet MagdaDirector15,960Jun 17, 20263
Jain RitaDirector19,194Jun 17, 20263
Tamboli AjimChief Financial Officer–May 14, 20262
Anaptysbio, Inc10% Owner0Apr 22, 20261
EcoR1 Capital, LLC10% Owner3,174,519IndirectApr 22, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 4, 2026 (view filing)4:25 PM ETSep 22 daysWare J. AnthonyDirectorSSale−39.3K$44.78−$1.76M−71.5%15.7K after
Apr 22, 2026 (view filing)Apr 202 daysEcoR1 Capital, LLC10% OwnerSSale+4.71M$13.81+$65.0MNew position3.17M after